Orthodontic Archwire Effectiveness Trial (ArchWireRaCE)

October 15, 2021 updated by: University of Dundee

ArchWire-RaCE: Orthodontic Archwires: a Randomised Clinical Trial of Effectiveness

This study protocol is for a randomised clinical trial which aims to test two materials used as orthodontic archwire to compare FireWire archwires to Copper Nickel Titanium (CNiTi) archwires. Both professional and patient related outcome measures are to be used to fully evaluate performance.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a randomised clinical trial of Firewire and CNiTi as orthodontic aligning archwires. A two group single blind parallel multicentre study design in a National Health Service primary care setting in England will be used.

Patients will be recruited from those attending the practices for orthodontic treatment that meet the inclusion and exclusion criteria. Online randomisation will allocate to one of the two groups, stratified by centre and age group (adolescent / adult).

Sample size calculation indicates a total sample size of 42, but allowing for dropouts and missing data the investigators will recruit 64, 32 to each group.

Patients will be treated according to a strict clinical protocol including customised Damon Q fixed appliances and defined archwire sequence. Participants will be seen at initial 5 week intervals for data collection after new archwire placement, and otherwise at routine 10 week intervals.

Primary outcome data (rate of alignment) will be collected over the initial 10 weeks and secondary outcomes over the duration of the treatment (18 months approx).

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 12 years of age or older
  • Class 1 Incisor relationship (British Standards Institute Classification)
  • Labial segment crowding in upper and / or lower arch >4mm
  • Little's Irregularity Index in upper and / or lower arch >4mm
  • Eligible for NHS orthodontic treatment
  • Planned non-extraction upper and lower fixed appliance orthodontic treatment

Exclusion Criteria:

  • Previous fixed appliance orthodontic treatment
  • Previous functional appliance treatment
  • Planned use of fixed auxiliary appliances (e.g. quadhelix, Trans Palatal Arch)
  • Cleft lip and palate or other craniofacial anomalies
  • Hypodontia (excluding third molars), or missing teeth due to previous extraction
  • Abnormal root morphology on pre-treatment radiographs
  • Confirmed history of nickel allergy
  • A medical history resulting in them taking analgesics for a chronic condition
  • Limited mouth opening or other contra-indication to intra-oral scanning

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Firewire
Experimental Group 1. Novel orthodontic archwire.
Archwire used to align teeth in an orthodontic fixed brace
Other Names:
  • Firewire
  • Copper Nickel Titanium
Experimental: CNiTi
Experimental Group 2. Current best available orthodontic archwire
Archwire used to align teeth in an orthodontic fixed brace
Other Names:
  • Firewire
  • Copper Nickel Titanium

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of tooth movement
Time Frame: Initial six months of treatment
Rate teeth move in response to force from archwire measured in millimetres on digital dental models
Initial six months of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessed by Visual Analogue Scale
Time Frame: Initial six months of treatment
Visual Analogue Scale pain score after archwire placed
Initial six months of treatment
Tooth Root Resorption assessed on panoramic radiograph using method of Pandis et al (2008)
Time Frame: 18 months
Damage to tooth root during tooth movement
18 months
Patient experience assessed by Questionnaire
Time Frame: Initial six months of treatment
Questionnaire of patient experiences of braces
Initial six months of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: David R Bearn, BDS, PhD, University of Dundee

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

April 1, 2019

Study Completion (Actual)

August 17, 2021

Study Registration Dates

First Submitted

January 14, 2016

First Submitted That Met QC Criteria

January 19, 2016

First Posted (Estimate)

January 20, 2016

Study Record Updates

Last Update Posted (Actual)

October 18, 2021

Last Update Submitted That Met QC Criteria

October 15, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malocclusion

Clinical Trials on Orthodontic archwire

3
Subscribe